Tvardi Therapeutics, Inc.
TVRDTvardi Therapeutics, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $7.1 million, down 66.0% from fiscal 2023.
- Revenue
- +20.3%
- EPS
- n/m
- Free cash flow
- n/m
Quarter to September 2026, against a year earlier
After hours trading: 0.97, down 2.02%, last trade Fri 7:28pm Eastern.
Follow TVRD
Alert me
Where the cash went Fiscal 2025, year to Dec 31, 2025
Free cash flow was −$23.5M: capital expenditures were more than operating cash flow. Cash fell by $10.9M. Lines the picture does not name came to +$22.2M. What is a cash flow statement?
- Free cash flow
- −$23.5M
- Returned to shareholders
- $0.00
- Debt, net
- $0.00 borrowed
- Change in cash
- −$10.9M over the period
| Operating cash flow | −23.5 |
|---|---|
| Free cash flow | −23.5 |
| Into investments, net | −10.1 |
| Shares issued, net | +0.5 |
| Other | +22.2 |
| Change in cash | −10.9 |
| FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | −$47M | −$55M | −$22M | −$109M | −$5.5M | −$60M | −$79M | −$92M | −$18M |
| Capex | −$0.7M | $0 | $0.0B | $0 | $0.0B | $0 | $0 | −$2.4M | −$1M |
| Free cash flow | −$48M | −$55M | −$22M | −$109M | −$5.8M | −$60M | −$79M | −$94M | −$19M |
Figures in millions of dollars. Free cash flow is operating cash flow less capital expenditures. Investments are purchases less sales of securities; “Other” is what the named lines leave of the change in cash.
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Net Income |
(18.21) | (29.40) | (118.51) | (85.47) | (88.44) | 8.41 | (106.37) | (74.01) | (58.12) | (57.28) |
Depreciation & Amortization |
(0.10) | 0.10 | 1.93 | 1.93 | 2.42 | 1.17 | (0.58) | (1.45) | (0.09) | 1.25 |
Non Cash Items (Other) |
(5.69) | 2.36 | 14.33 | 17.73 | 20.68 | 14.56 | 16.57 | 9.94 | 6.43 | 2.66 |
Accounts Receivable Change |
— | 1.32 | 0.44 | (3.30) | 0.10 | 0.41 | (0.04) | (0.80) | (0.04) | (0.01) |
Change in inventories |
— | (1.04) | (0.44) | 0.20 | (2.58) | — | — | — | — | — |
Change in payables and accrued liability |
0.92 | 5.57 | 3.28 | 5.68 | (1.02) | (2.78) | 6.04 | 5.12 | (3.03) | 6.27 |
Income tax paid |
— | 0.70 | — | — | 0.81 | (0.69) | (0.15) | 0.07 | 0.12 | (0.47) |
Change in other assets and liabilities |
(0.41) | 3.07 | 7.00 | (15.50) | 7.96 | (26.57) | (24.68) | 38.84 | (0.10) | 0.20 |
Other operating activities |
— | — | (0.11) | — | — | — | — | — | — | — |
Operating Cash Flow |
(23.50) | (18.30) | (92.08) | (78.73) | (60.09) | (5.49) | (109.22) | (22.30) | (54.83) | (47.38) |
Capital expenditures |
— | (1.05) | (2.37) | (0.04) | 0.03 | (0.35) | (0.02) | (0.07) | (0.02) | (0.72) |
Short Term Investments Change (Net) |
(10.08) | 49.79 | 45.84 | 128.75 | (4.78) | (19.93) | (30.50) | (82.75) | (36.48) | 45.74 |
Investing cash flow |
(10.08) | 48.74 | 43.46 | 128.71 | (4.75) | (20.27) | (30.52) | (82.82) | (36.50) | 45.02 |
Repayment/Issuance of Debt (Net) |
— | 28.30 | — | (1.75) | (1.60) | (1.09) | (0.88) | — | — | — |
Equity Repurchase (Common, Net) |
0.53 | 0.01 | 1.68 | 0.31 | 46.61 | 39.14 | 142.60 | 110.81 | 87.92 | 0.12 |
Other financial activities |
22.17 | (1.30) | 36.47 | 18.00 | 21.54 | (7.54) | (4.56) | 8.12 | 5.85 | 2.45 |
Financing cash flow |
22.70 | 27.00 | 38.15 | 0.31 | 46.61 | 39.14 | 142.60 | 110.81 | 87.92 | 0.12 |
Change in Cash |
(10.88) | 8.70 | (10.47) | 50.29 | (18.23) | 13.38 | 2.86 | 5.69 | (3.40) | (2.24) |
Beginning Cash |
31.61 | 22.92 | 64.15 | 13.86 | 32.09 | 18.71 | 15.85 | 10.16 | 13.56 | 15.80 |
Ending Cash |
20.73 | 31.61 | 53.68 | 64.15 | 13.86 | 32.09 | 18.71 | 15.85 | 10.16 | 13.56 |
Stock Based Compensation |
1.40 | 0.32 | 13.73 | 17.73 | 20.79 | 14.84 | 12.57 | 9.48 | 5.79 | 2.80 |
Dividends Paid (Common) |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash/Marketcap |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Assets Liabilities Change (Total) |
0.51 | 8.64 | 10.28 | (12.92) | 5.26 | (29.63) | (18.84) | 43.22 | (3.05) | 5.99 |
Investments Change (Net) |
(10.08) | 49.79 | 45.84 | 128.75 | (4.78) | (19.93) | (30.50) | (82.75) | (36.48) | 45.74 |
Issuance/Purchase of Shares |
0.53 | 0.01 | 1.68 | 0.31 | 46.61 | 39.14 | 142.60 | 110.81 | 87.92 | 0.12 |
| Other line items | ||||||||||
Revenue per Employee |
— | 0.71 | 0.38 | 0.39 | 0.27 | 1.69 | 0.30 | 0.24 | 0.02 | 0.00 |